Article info

Download PDFPDF

362 Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivo
Free

Authors

  • P Holý Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic Third Faculty of Medicine, Charles University, Prague, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • K Seborova Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • A Spalenkova Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic Third Faculty of Medicine, Charles University, Prague, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • K Koucka Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • M Ehrlichova Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • C Wang Institute of Chemical Biology and Drug Discovery – Stony Brook University – State University of New York, Stony Brook, NY, USA PubMed articlesGoogle scholar articles
  • I Ojima Institute of Chemical Biology and Drug Discovery – Stony Brook University – State University of New York, Stony Brook, NY, USA PubMed articlesGoogle scholar articles
  • P Daniel Third Faculty of Medicine, Charles University, Division of Cell and Molecular Biology, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • K Balusikova Third Faculty of Medicine, Charles University, Division of Cell and Molecular Biology, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • M Jelinek Third Faculty of Medicine, Charles University, Division of Cell and Molecular Biology, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • J Kovar Third Faculty of Medicine, Charles University, Division of Cell and Molecular Biology, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • P Soucek Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • R Vaclavikova Biomedical Center, Charles University Faculty of Medicine in Pilsen, Laboratory of Pharmacogenomics, Pilsen, Czech Republic National Institute of Public Health, Prague, Toxicogenomics Unit, Prague, Czech Republic PubMed articlesGoogle scholar articles

Citation

Holý P, Seborova K, Spalenkova A, et al
362 Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivo

Publication history

  • First published October 12, 2021.
Online issue publication 
October 12, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.